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ABSTRACT
Newly synthesized mRNA is translated during its
export through the nuclear pore complex, when its
5′-cap structure is still bound by the nuclear cap-
binding complex (CBC), a heterodimer of cap-binding
protein (CBP) 80 and CBP20. Despite its critical role
in mRNA surveillance, the mechanism by which CBC-
dependent translation (CT) is regulated remains un-
known. Here, we demonstrate that the CT initiation
factor (CTIF) is tethered in a translationally incompe-
tent manner to the perinuclear region by the DEAD-
box helicase 19B (DDX19B). DDX19B hands over
CTIF to CBP80, which is associated with the 5′-cap
of a newly exported mRNA. The resulting CBP80–
CTIF complex then initiates CT in the perinuclear re-
gion. We also show that impeding the interaction
between CTIF and DDX19B leads to uncontrolled
CT throughout the cytosol, consequently dysregu-
lating nonsense-mediated mRNA decay. Altogether,
our data provide molecular evidence supporting the
importance of tight control of local translation in the
perinuclear region.
INTRODUCTION
In the nucleus of mammalian cells, newly synthesized pre-
mRNAs are processed into mature mRNAs via multiple
steps, including 5′ capping, splicing, and 3′ polyadenylation.
The 5′-cap structure of mRNAs is recognized by the nuclear
cap-binding complex (CBC), a heterodimer of cap-binding
protein (CBP) 80 and CBP20 (1–4). After complete process-
ing in the nucleus, mRNAs are exported to the cytoplasm
via the nuclear pore complex (NPC) (5). During or immedi-
ately after the export, the mRNAs are subjected to the pio-
neer (or first) round of translation, which frequently occurs
with the CBC bound to the 5′-cap of the mRNAs. CBC-
dependent translation (CT) preferentially involves the CT
initiation factor (CTIF), which links the CBC and eukary-
otic translation initiation factor (eIF) 3, promoting the re-
cruitment of a small ribosomal subunit to the 5′-end of the
mRNA (6).
In the cytoplasm, the CBC associated with the 5′-cap
structure of the mRNAs is eventually replaced by eIF4E,
the major cytoplasmic cap-binding protein, in a translation-
independent manner and mediated by importins  and 
(7,8). A recent study further showed that the CBC-to-eIF4E
replacement step is regulated by the coordinated actions of
UPF1 and Staufen1, a negative and positive regulator, re-
spectively (9). The resulting eIF4E-bound mRNAs are ac-
tively translated using eIF4G, which acts as a scaffold pro-
tein to link eIF4E and eIF3 to recruit the small ribosomal
subunit to the mRNA (10).
CT plays an important role in nonsense-mediated mRNA
decay (NMD), a well-characterized mRNA surveillance
pathway that degrades a subset of normal mRNAs as
well as faulty mRNAs containing a premature termination
codon (PTC) (2,11–14). In addition, several recent studies
have suggested that CT is associated with a protein surveil-
lance mechanism called the aggresome–autophagy path-
way, in which newly generated misfolded polypeptides are
selectively transported to the perinuclear aggresome and
eventually eliminated from the cell by autophagy (15–17).
The DEAD-box RNA helicase 19B (DDX19B, a human
homolog of yeast Dbp5) consists of an N-terminal exten-
sion helix and two RecA-like domains, which are struc-
turally similar to each other and participate in ATP binding
and hydrolysis (18,19). DDX19B localizes in the cytoplas-
mic side of the NPC in the perinuclear region via its asso-
ciation with NUP214 (a cytoplasmic NPC component) and
plays a critical role in mRNA export from the nucleus to the
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cytoplasm with the help of GLE1 and inositol 1,2,3,4,5,6-
hexakisphosphate (20–22). Furthermore, DDX19B inter-
acts with eukaryotic release factor 1 (eRF1) and is involved
in translation termination (23–25). In addition, DDX19B
stabilizes ribosome complexes with eukaryotic elongation
factor (eEF) 1 and eEF2 (26).
In this study, we demonstrate that CT is restricted to the
perinuclear region via an interaction between CTIF and
DDX19B. Disruption of the CTIF–DDX19B interaction
causes CTIF redistribution and uncontrolled CT through-
out the cytoplasm, consequently leading to the dysregula-
tion of NMD. Therefore, our data elucidate the importance
of tight control of local translation in the perinuclear region.
MATERIALS AND METHODS
Cell culture and generation of stable cell lines
HeLa (female; ATCC), HEK293T (fetal; ATCC) and
HEK293FT (fetal; ATCC) cells stably expressing Myc-
eIF4E were cultured in Dulbecco’s modified Eagle’s
medium (DMEM; Capricorn Scientific) supplemented with
10% (v/v) fetal bovine serum (Capricorn Scientific) and 1%
(v/v) of a penicillin/streptomycin solution (Capricorn Sci-
entific).
To create HEK293FT cells stably expressing Myc-eIF4E,
HEK293FT cells were co-transfected with a plasmid ex-
pressing Myc-eIF4E and a plasmid encoding a puromycin
resistance gene. Two days later, the cells were serially di-
luted and grown in DMEM supplemented with 1 g/ml
puromycin (MilliporeSigma). Single-cell colonies were iso-
lated and analyzed by western blotting. The resulting cell
lines were cultured in DMEM with 0.5 g/ml puromycin.
Plasmid construction
The following plasmids described previously have been
used: pcDNA3-FLAG and pcDNA3-FLAG-CBP80
(27); pcDNA3-FLAG-eIF4E, pcDNA3-FLAG-CTIF,
pcDNA3-FLAG-CTIF (1–305), pcDNA3-FLAG-CTIF
(306–598) (6), pmCMV-Gl-Norm and -Ter, pmCMV-
GPx1-Norm and -Ter, and phCMV-MUP (6); pcDNA3.1-
HA (28); pCMV-Myc-eIF4E (29); pcDNA3.1-CBP80-HA
(9); pCI-neo (Promega); and pCMV-Myc (Clontech).
pcDNA3-FLAG-CTIF-F460A was generated by site-
directed mutagenesis of pcDNA3-FLAG-CTIF as a tem-
plate.
To construct pcDNA3-FLAG-CTIF-WT-KASH1
and pcDNA3-FLAG-CTIF-F460A-KASH1, an in vitro-
synthesized DNA fragment encoding the KASH1 domain
(including the transmembrane domain) of the nesprin-1
gene (NM 182961.4) was inserted into the 3′-end of CTIF
cDNA in pcDNA3-FLAG-CTIF or pcDNA3-FLAG-
CTIF-F460A, respectively.
To generate pCI-neo-DDX19B-WT-HA, pCI-neo-HA
was first constructed by inserting a fragment encoding
HA from pcDNA3.1-HA into pCI-neo. Next, the cDNA
fragment encoding full-length DDX19B (NM 007242) was
amplified by PCR from pOTB7-DDX19B (Korea Human
Gene Bank; Daejeon, Korea). The PCR-amplified frag-
ment was inserted into pCI-neo-HA. pCI-neo-DDX19B-
W6A/V10A-HA was constructed by site-directed mutage-
nesis of pCI-neo-DDX19B-WT-HA as a template.
pCI-neo-DDX19BR-WT-HA and pCI-neo-DDX19BR-
W6A/V10A-HA were constructed by replacing DDX19B
siRNA target sequences from 5′-CCTGAACTGAAGCT
AGCTT-3′ to 5′-CCAGAGTTAAAATTGGCAT-3′.
pCI-neo-DDX19B(1–300)-HA expressing the N-
terminal half of DDX19B and pCI-neo-DDX19B(301–
479)-HA expressing the C-terminal half of DDX19B were
generated by replacing the DDX19B-WT sequences in
pCI-neo-DDX19B-WT-HA with a PCR-amplified frag-
ment encoding the N- and C-terminal halves of DDX19B,
respectively.
To construct pBiFC-HA-CTIF-WT-VC155 and pBiFC-
HA-CTIF-F460A-VC155, a cDNA fragment encoding full-
length CTIF or CTIF-F460A, respectively, was inserted be-
tween HA and VC155 of pBiFC-HA-VC155 (30).
To construct pBiFC-FLAG-DDX19B-VN173, a PCR-
amplified DDX19B fragment was inserted between FLAG
and VN173 of pBiFC-FLAG-VN173 (30).
DNA or siRNA transfection
HeLa cells were transiently transfected with plasmid(s)
using either Lipofectamine 2000 (Life Technologies) or
jetPRIME® (Polyplus Transfection) as described previ-
ously (31–33). For immunoprecipitation (IP) or polysome
fractionation analysis using HEK293T or HEK293FT cells,
the calcium phosphate transfection method was employed.
To downregulate endogenous proteins, cells were
transfected with 100 nM in vitro-synthesized siRNAs
(GenePharma) using Lipofectamine 3000 (Invitrogen). The
following siRNA sequences were used in this study: 5′-r(GG
AAGAAGCUAAAGAGAAA)d(TT)-3′ (human CBP80
siRNA), 5′-r(AAAAACAAAUCAUUAGUAG)d(TT)-3′
(human DDX19A siRNA), 5′-r(CCUGAACUGAAGCU




Primary antibodies against the following proteins were
utilized for western blotting, IPs, or immunostaining
[listed in the format ‘protein name (catalog number, sup-
plier)’]: DDX19A (ARP36455 T100, Aviva System Biol-
ogy); DDX19B (ab70305, Abcam); lamin A/C (sc-376248,
Santa Cruz Biotechnology); eIF4E (2067, Cell Signal-
ing Technology); eIF3b (sc-16377, Santa Cruz Biotech-
nology), -actin (A5441, Sigma); GAPDH (LF-PA0212,
AbFrontier); FLAG (A8592 or F1804, Sigma); HA
(11867431001, Roche); Myc (9E10; OP10L, Calbiochem);
U1 snRNP 70 (sc-390899, Santa Cruz Biotechnology);
CBP80, eIF4G1 and CTIF (6); and eIF4A3 (32).
Immunoprecipitations and RNA immunoprecipitation
These procedures were performed as previously described
(15,31,33). Briefly, HEK293T cells were harvested and re-
suspended in NET-2 buffer [50 mM Tris–HCl (pH 7.4), 150
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2 mM benzamidine hydrochloride (Sigma), 0.05% NP-
40 (IGEPAL® CA-630; Sigma), 10 mM sodium fluoride
(Sigma), and 0.25 mM sodium orthovanadate (Sigma)]. The
resuspended cells were lysed by sonication and centrifuged
for 10 min at 4◦C and 13 800 × g. Cell lysates were pre-
cleared using protein G or A agarose 4B (Incospharm) for
1 h at 4◦C. The pre-cleared supernatant was incubated with
antibody-conjugated beads for 3 h at 4◦C. The protein-
bound beads were washed five times with NET-2 buffer,
and the proteins were eluted with 2× sample buffer [10%
-mercaptoethanol, 4% SDS, 100 mM Tris–HCl (pH 6.8),
15% glycerol and 0.008% bromophenol blue]. The coim-
munoprecipitated proteins were analyzed by western blot-
ting. For quantification, the signal intensities of western
blot bands were quantified using ImageJ software (National
Institutes of Health, Bethesda, MD).
The RNA-IP protocol was similar to the IP protocol, ex-
cept that tRNA-saturated and antibody-conjugated beads
were used. After RNA-IPs, coimmunoprecipitated RNA
and proteins were eluted with 2× sample buffer. The eluted
coimmunoprecipitated RNAs were extracted with phenol,
chloroform and isoamyl alcohol and subjected to cDNA
synthesis using RevertAid Reverse Transcriptase (Thermo
Fisher Scientific).
Quantitative real-time RT-PCR
qRT-PCR analyses were performed with gene-specific
oligonucleotides and the Light Cycler 480 SYBR Green
I Master Mix (Roche) on a Light Cycler 480 II machine
(Roche). The following gene-specific oligonucleotides were
used in this study: 5′-ACCACCGTAGAACGCAGATC
G-3′ (sense) and 5′-CTTCTCACCATTCACCTCGCAC
TT-3′ (antisense) for the amplification of GPx1-Norm
or -Ter mRNAs; 5′-ACCACCGTAGAACGCAGATCG-
3′ (sense) and 5′-GGGTTTAGTGGTACTTGTGAGC-3′
(antisense) for the amplification of Gl-Norm or -Ter mR-
NAs; 5′-CTGATGGGGCTCTATG-3′ (sense) and 5′-TC
CTGGTGAGAAGTCTCC-3′ (antisense) for the ampli-
fication of MUP mRNAs; 5′-GTGAAAAGCCTCCTTC
TGG-3′ (sense) and 5′-CTGTAGAACTGAGGCAAGG-
3′ (antisense) for the amplification of COMMD7 mRNAs;
5′-CAACATGACGCTGGAAGAGC-3′ (sense) and 5′-TC
AATGGCCAAGAGGCAGAG-3′ (antisense) for the am-
plification of GADD45B mRNAs; and 5′-TGGCAAATTC
CATGGCACC-3′ (sense) and 5′-AGAGATGATGACCC
TTTTG-3′ (antisense) for the amplification of GAPDH
mRNAs.
Polysome fractionation analysis
Polysome fractionation of HEK293FT cells was carried
out as described previously (6,32). Briefly, HEK293FT cells
were cultured in 150 mm culture dishes and preincubated
in a culture medium containing 100 g/ml cycloheximide
(Sigma) for 10 min before cell harvest. The cells were
washed with PBS containing 100 g/ml cycloheximide and
collected by centrifugation at 2000 × g for 10 min. The
pellet was resuspended and lysed in polysome cell extrac-
tion buffer [50 mM MOPS (3-(N-morpholino) propanesul-
fonic acid; Sigma), 15 mM MgCl2 (Sigma), 150 mM NaCl
(Sigma), 100 g/ml cycloheximide, 0.5% (v/v) Triton X-100
(Sigma), 1 mg/ml heparin sodium salt (Sigma), 0.2 U/l
RiboLock RNase inhibitor (Thermo Fisher Scientific), 2
mM phenylmethanesulfonyl fluoride (Sigma), and 1 mM
benzamidine hydrochloride (Sigma)]. After centrifugation
at 13 000 × g for 10 min, the supernatant was loaded onto
a sucrose gradient bar (10–50%) and subjected to centrifu-
gation at 36 000 rpm for 2 h (Optima XE-90 Ultracen-
trifuge, Beckman Coulter) with maximum speed accelera-
tion and natural deceleration. For collecting fractions ac-
cording to A254, a Foxy Jr Density Gradient System (Tele-
dyne ISCO) was used. The polysome-fractionated samples
were collected as 11 fractions for western blotting (Figures 5
and 6) or seven fractions for IP experiments (Figure 7). The
intensities of the western blot images in each fraction were
quantitated using Multi Gauge (Fujifilm), and the values of
each fraction were presented as a percentage of the sum of
the intensities.
Nucleocytoplasmic fractionation
Nuclear and cytoplasmic fractions were obtained from
HEK293T cells, as previously described (34). Briefly, cells
were lysed with hypotonic buffer [10 mM Tris–HCl (pH
7.4), 10 mM NaCl, 0.1% Triton X-100 (Sigma), 10 mM
EDTA (pH 8.0), 1 mM phenylmethylsulfonyl fluoride
(Sigma) and 2 mM benzamidine hydrochloride (Sigma)]
and incubated for 10 min on ice. After centrifugation at 13
800 × g for 10 min at 4◦C, the supernatant was considered
as the cytoplasmic fraction. The pellets were washed three
times with a hypotonic buffer and centrifuged at 13 800 × g
for 3 min at 4◦C. The resuspended pellet was sonicated and
centrifuged for 10 min at 4◦C at 13 800 × g. The supernatant
was considered as the nuclear fraction.
Yeast two-hybrid assay
Yeast two-hybrid (Y2H) screening assays were performed
by Panbionet (Pohang, Korea).
Immunostaining
This procedure was performed on HeLa cells as described
previously (15). The cells were treated with formaldehyde
(Sigma, F8775) and Triton X-100 (0.5%; Sigma, T8787)
for fixation and permeabilization, respectively. Next, the
cells were blocked with bovine serum albumin (BovoStar)
and incubated for 1 h with a primary antibody and for
another 1 h with secondary antibodies conjugated with
Alexa Fluor 488, Alexa Fluor 568 or rhodamine. Nuclei
were stained with 4′,6-diamidino-2-phenylindole (DAPI;
Biotium). The cells were visualized under an LSM 510
Meta, LSM700 or LSM 800 microscope (Carl Zeiss). Zeiss
LSM Image Browser and Zen 2.1 (black; Carl Zeiss) were
used for the analysis of immunostained cell images. Fluores-
cence intensities were measured across the indicated lengths
and directions using ImageJ software (National Institutes
of Health, Bethesda, MD, USA).
Bimolecular fluorescence complementation (BiFC) assay
This assay was conducted as described previously
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HeLa cells transiently transfected with BiFC plasmids
were incubated for 8 h at 37◦C and then fixed in 2%
formaldehyde for 10 min at room temperature.
Statistics
Two-tailed, equal-sample variance Student’s t-test was per-
formed for statistical analysis, with the difference being con-
sidered statistically significant at *P < 0.05 and **P < 0.01.
In most cases, data obtained from at least two indepen-
dently performed biological replicates were analyzed, unless
indicated otherwise in the figure legends. Data are presented
as the mean ± standard deviation.
RESULTS
Identification of DDX19B as a CTIF-interacting protein
To gain more insights into the molecular mechanism under-
lying CT, we searched for CTIF-interacting proteins. To this
end, we conducted yeast two-hybrid screening using (i) the
GAL4 DNA-binding domain (BD)-fused CTIFN (lack-
ing the N-terminal half of CTIF) as bait and (ii) the GAL4
transcription activation domain (AD)-fused human thymus
cDNA library. In two independent yeast two-hybrid screen-
ing assays, 47 independent positive colonies were obtained.
Among them, 19, 7 and 17 colonies contained a plasmid
encoding DDX19B, DDX19A and stem–loop binding pro-
tein (SLBP), respectively (Supplementary Figure S1). The
remaining colonies contained a plasmid encoding RPS20,
MIF4GD, DDX50 or ZNF26. Notably, the rapid degra-
dation of replication-dependent histone mRNAs via an in-
teraction between CTIF and SLBP largely occurs on CBC-
associated mRNAs (36).
Because DDX19B (and its paralogue, DDX19A) was
screened out most frequently in our yeast two-hybrid
screening assays, we next validated the interaction be-
tween CTIF and DDX19B (and DDX19A). First, a yeast
two-hybrid assay involving BD-CTIFN and either AD-
DDX19B or AD-DDX19A yielded positive signals in three
different assays, indicating an interaction between these two
proteins: (i) blue color on a medium containing X-gal (Fig-
ure 1A, the filter assay), (ii) growth on a medium lacking
uracil (Figure 1A, SD-LWU) and (iii) growth on a medium
lacking adenine (Figure 1A, SD-LWA). Second, endoge-
nous DDX19B was found to be preferentially enriched in
immunoprecipitations (IPs) of FLAG-CTIF (Figure 1B)
in an RNase A-resistant manner, indicating that this in-
teraction is not mediated by RNA. In addition, endoge-
nous CTIF was preferentially copurified with endogenous
DDX19B (Figure 1C). In agreement with previous studies
(6,29,32,36), CBP80, eIF3b (a component of the eIF3 com-
plex), and eIF4A3 (a component of the exon junction com-
plex), but not eIF4E and eIF4G1, were also specifically de-
tected in the IPs of FLAG-CTIF in an RNase A treatment-
resistant manner (Figure 1B and C). Confirming the ef-
ficiency of RNase A treatment, semiquantitative reverse-
transcription PCR (sqRT-PCR) showed almost complete
depletion of endogenous GAPDH mRNA after RNase A
treatment (Figure 1B, lower panel). Finally, DDX19B was
found to be preferentially enriched in the IPs of CTIF wild-
type (WT) or CTIF 306–598 (corresponding to CTIFN)
but not of CTIF 1–305 (the N-terminal half of CTIF; Figure
1D). In addition, endogenous CTIF selectively coimmuno-
precipitated with DDX19B-WT-HA or the N-terminal half
of DDX19B (1–300) but not with the C-terminal half of
DDX19B (301–479) (Figure 1E). Collectively, our data indi-
cate that the C-terminal MIF4G domain of CTIF interacts
with the N-terminal half of DDX19B.
CBP80 partially competes with DDX19B to bind to CTIF
Interestingly, an increased amount of endogenous
DDX19B and CBP80 was enriched in the IPs of the
C-terminal half and N-terminal half of CTIF, respec-
tively, compared with that of the full-length CTIF-WT
(Figure 1D), and CBP80 was not detectable in the IPs of
endogenous DDX19B (Figure 1C). These observations
prompted us to hypothesize that CBP80 might compete
with DDX19B for binding to CTIF, even though the N-
and C-terminal halves of CTIF are sufficient for interacting
with CBP80 and DDX19B, respectively (Figure 1).
To test this hypothesis, we carried out IPs in the ex-
tracts of cells that transiently expressed FLAG-CTIF and
were either depleted or not of endogenous DDX19B by
means of a specific small interfering RNA (siRNA). Down-
regulation of DDX19B to ∼10% of the level in unde-
pleted cells increased the amount of coimmunoprecipitated
CBP80 by 2.6-fold in the IPs of FLAG-CTIF (Figure 2A).
Conversely, ∼2.5-fold more DDX19B was found to be en-
riched in the IP of FLAG-CTIF when the cells were de-
pleted of endogenous CBP80 (Figure 2B), indicating a com-
petition between CBP80 and DDX19B for binding to CTIF.
Notably, DDX19A also had the ability to compete with
CBP80 for binding to CTIF, showing an additive effect with
DDX19B (Supplementary Figure S2). However, the abil-
ity of DDX19A was relatively weak compared with that
of DDX19B (Supplementary Figure S2), suggesting a pre-
dominant role of DDX19B in the competition.
The C-terminal MIF4G domain of Homo sapiens CTIF
(HsCTIF) is similar to the MIF4G domain of SLBP-
interacting protein 1 (SLIP1) in the amino acid sequence,
and HsDDX19B is homologous to the DBP5 of zebrafish
(Danio rerio, Dr). Based on available structural data on
the interaction between DrSLIP1 and DrDBP5 (37) (Fig-
ure 2C and D), we determined the amino acid residues
that were most likely critical for the CTIF–DDX19B in-
teraction. Along with the sequence alignment analysis of
HsDDX19B and DrDBP5, we predicted that the amino
acids, W6 and V10, of DDX19B would be important for
its binding to CTIF (Supplementary Figure S3A). In addi-
tion, after sequence alignment analysis of the MIF4G do-
main of HsCTIF, DrSLIP1, and HsSLIP1 (Supplementary
Figure S3B), the amino acid F460 of CTIF was predicted
to be important for its binding to DDX19B, since the cor-
responding residue of DrSLIP1 (F87) is required for bind-
ing to DrDBP5 (Figure 2D). As predicted, substitutions of
tryptophan and valine with alanines at positions 6 and 10
of DDX19B (DDX19B-W6A/V10A) abrogated the inter-
action between DDX19B and CTIF (Figure 2E). Consis-
tently, the substitution of phenylalanine with alanine at po-
sition 460 of CTIF (CTIF-F460A) also disrupted the inter-
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Figure 1. CTIF interacts with DDX19B. (A) Yeast two-hybrid analysis using BD-CTIFN and AD-DDX19. The yeast strain PBN204 was co-transformed
with two plasmids expressing the indicated BD- and AD-fusion proteins. Yeast cells harboring the two plasmids were selected on a synthetic defined (SD)
medium lacking leucine and tryptophan (Master plate; SD-LW). In our yeast two-hybrid system, a specific interaction between the BD- and AD-fusion
proteins enables (i) the appearance of a blue color (LacZ expression; the filter assay), (ii) the growth on an SD medium lacking leucine, tryptophan,
and uracil (SD-LWU), and (iii) the growth on an SD medium lacking leucine, tryptophan, and adenine (SD-LWA). The well-characterized dimerization of
polypyrimidine tract–binding protein served as the positive control (+), and empty vectors expressing only BD and AD served as the negative control (–). (B)
Immunoprecipitation (IP) of FLAG-CTIF before or after RNase A treatment. HEK293T cells were transiently transfected with a plasmid expressing either
FLAG alone or FLAG-tagged CTIF-WT. Two days later, the cells were harvested, lysed, and the cell extracts were either treated or not treated with RNase
A before IP with anti-(-) FLAG antibody. The protein samples before or after IP were analyzed by western blotting with antibodies against the indicated
proteins. Efficient RNA degradation by the treatment with RNase A was assessed by detecting endogenous GAPDH mRNA using semiquantitative reverse-
transcription PCR (sqRT-PCR). (C) IP of endogenous DDX19B before or after RNase A treatment. As performed in panel B, except that IP experiments
were carried out with -DDX19B antibody or nonspecific rabbit IgG (rIgG). To show that western blots were semiquantitative, the cell extracts before IP
were serially diluted by 3-fold and loaded in the four leftmost lanes. (D) IP of FLAG-CTIF-WT or its deletion variants. As performed in panel B, except
that the cells were transiently transfected with a plasmid expressing FLAG, FLAG-CTIF-WT, or one of its deletion variants, and RNase A treatment was
applied before IP. Band intensities in each western blot image were quantified. Intensities of coimmunoprecipitated DDX19B and CBP80 were normalized
to those of immunoprecipitated FLAG-CTIF-WT or its variants. The normalized levels of coimmunoprecipitated DDX19B and CBP80 in the IP of
FLAG-CTIF-WT were arbitrarily set to 1.0. (E) IP of DDX19B-WT-HA or one of its deletion variants. As performed in panel D, except that the cells were
transfected with a plasmid expressing DDX19B-WT-HA or one of its deletion variants, and IPs were carried out with the -HA antibody or nonspecific
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Figure 2. CBP80 competes with DDX19B for binding to CTIF. (A) IP of FLAG-CTIF in the extracts of cells depleted of DDX19B. HEK293T cells either
depleted or not depleted of endogenous DDX19B were transiently transfected with a plasmid expressing either FLAG or FLAG-CTIF-WT. The relative
levels of coimmunoprecipitated DDX19B and CBP80 were quantified and are presented at the bottom of each image. Data are presented as the mean
± standard deviation; n = 2. (B) IPs of FLAG-CTIF in the extracts of cells depleted of CBP80. As performed in panel A, except that HEK293T cells
were either depleted or not depleted of endogenous CBP80; n = 2. (C) Schematic illustration of DDX19B, CTIF and CBP80. CTIF consists of a CBP80-
interacting domain (yellow) and a middle domain of eIF4G (MIF4G) domain (orange). The point mutations characterized in this study are indicated
by red arrowheads. (D) Structure of a Danio rerio SLIP1 (DrSLIP1) and DrDBP5 complex (PDB: 4JHJ). The hydrophobic property is presented in the
molecular surface of DrSLIP1: the more intense the red color is, the stronger is the hydrophobicity. Ribbon diagrams of DrDBP5 are shown in blue. Two
important residues (W6 and V10) of DrDBP5 for interacting with DrSLIP1 are specified. In addition, the amino acid residues involved in the hydrophobic
interaction between DrDBP5 and DrSLIP1 are indicated. The predicted amino acid residues important for an interaction between Homo sapiens CTIF
(HsCTIF; homologous to DrSLIP1) and HsDDX19B (homologous to DrDBP5) are indicated in brackets. (E) IP of DDX19B-WT-HA or its W6A/V10A
variant. Extracts of HEK293T cells expressing either DDX19B-WT-HA or DDX19B-W6A/V10A-HA were subjected to IPs with either -HA antibody
or rat IgG; n = 2. (F) IP of FLAG-CTIF or its F460A variant. Extracts of HEK293T cells expressing FLAG, FLAG-CTIF-WT or FLAG-CTIF-F460A
were subjected to IP with the -FLAG antibody; n = 2.
approximately 2.8-fold more endogenous CBP80 was found
to be enriched in the IP of CTIF-F460A compared to the IP
of CTIF-WT, providing further evidence that CBP80 and
DDX19B compete for binding to CTIF. It is likely that the
observed competition may be due to steric hindrance be-
tween CBP80 and DDX19B, even though the minimal re-
gions responsible for binding to CBP80 and DDX19B were
assigned to the N- and C-terminal halves of CTIF, respec-
tively.
DDX19B tethers CTIF to the perinuclear region
It has been previously shown that DDX19B localizes
throughout the cytoplasm with pronounced enrichment in
the perinuclear region owing to its interaction with NUP214
(38,39). In addition, CTIF is largely enriched in the cy-
toplasmic side of the nuclear envelope (6) as well as in
the perinuclear aggresome (15,16) with some degree of cy-
toplasmic accumulation. Based on these observations, we
tested whether the interaction between CTIF and DDX19B
is responsible for the perinuclear localization of CTIF or
DDX19B. Confocal microscopy revealed that the major-
ity of CTIF-WT overlapped with endogenous lamin A/C,
which is a component of the nuclear lamina and is lo-
cated on the nucleoplasmic side of the inner nuclear mem-
brane (6). In contrast, CTIF-F460A was evenly distributed
throughout the cytoplasm (Figure 3A), indicating that the
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Figure 3. DDX19B tethers CTIF to the perinuclear region. (A) Immunostaining of FLAG-CTIF-WT or FLAG-CTIF-F460A. HeLa cells transiently
expressing FLAG, FLAG-CTIF-WT, or FLAG-CTIF-F460A were fixed with formaldehyde and stained with -FLAG (red) and -lamin A/C antibodies
(green). Nuclei were visualized by DAPI (blue). Representative confocal images from three biological replicates (n = 3) are provided. (B) Immunostaining of
endogenous CTIF in HeLa cells depleted of endogenous DDX19B. HeLa cells were either depleted or not depleted of endogenous DDX19B. The cells were
stained with -CTIF antibody (red) and -lamin A/C antibodies (green); n = 2. (C) Immunostaining of DDX19B-WT-HA or DDX19B-W6A/V10A-HA;
n = 3. (D) In vivo bimolecular fluorescence complementation (BiFC) assay. HeLa cells were transiently co-transfected with plasmids expressing DDX19B-
VN and either CTIF-WT-VC or CTIF-F460A-VC. The Venus fluorescent signal (yellow) was examined by confocal microscopy; n = 2; scale bar, 10
m.
with DDX19B. In support of this notion, downregulation
of endogenous DDX19B caused redistribution of endoge-
nous CTIF from the perinuclear region into the entire cyto-
plasm (Figure 3B).
Next, we monitored the relative distribution of DDX19B-
WT-HA and DDX19B-W6A/V10A-HA. Both proteins
showed similar intracellular distributions: localization
throughout the cytoplasm with enrichment in the perinu-
clear region (Figure 3C). These data indicate that, unlike
DDX19B-dependent perinuclear localization of CTIF, the
perinuclear localization of DDX19B is independent of its
interaction with CTIF.
We also carried out a BiFC assay (30,35), which allows
us not only to determine a specific interaction between two
proteins of interest within the cell but also to visualize where
an interaction between two proteins takes place in the cell.
To this end, in HeLa cells, we transiently expressed two
fusion proteins: (i) a DDX19B-fused N-terminal fragment
of Venus [an enhanced yellow fluorescent protein (VFP);
VN] and (ii) either a CTIF-WT–fused or CTIF-F460A–
fused C-terminal fragment of VFP (VC). In this assay, an
interaction between the two studied fusion proteins brings
VN and VC into close proximity, allowing their assembly
into a functionally active VFP, which emits VFP signals.
The BiFC results revealed that DDX19B-VN and CTIF-
WT-VC yielded ample VFP signals in the perinuclear re-
gion, whereas DDX19B-VN and CTIF-F460A-VC emitted
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specific interaction between CTIF and DDX19B in the per-
inuclear region. Collectively, our results demonstrate that
CTIF interacts with DDX19B predominantly in the perin-
uclear region and that this interaction is crucial for the per-
inuclear localization of CTIF.
Failure of an interaction between DDX19B and CTIF causes
accumulation of CBP80 in the cytoplasm
The failure of an interaction between DDX19B and CTIF
releases a perinuclear CTIF to the cytoplasm (Figure 3A
and B). Because CBP80 competes with DDX19B for bind-
ing to CTIF, the released cytoplasmic CTIF may be asso-
ciated with CBP80 and is expected to drive the accumu-
lation of CBP80 in the cytoplasm. As expected, we ob-
served that a small portion of endogenous CBP80 was re-
distributed from the nucleus to the cytoplasm, either when
the cells were overexpressed with CTIF-F460A, but not
with CTIF-WT (Figure 4A), or when the cells were de-
pleted of DDX19B. Remarkably, the expression of siRNA-
resistant DDX19B (DDX19BR)-WT, but not DDX19BR-
W6A/V10A, in DDX19B-depleted cells reversed the redis-
tribution of endogenous CBP80 (Figure 4B). The observed
partial redistribution of CBP80 was further validated by
western blotting using nuclear and cytoplasmic fractions
(Supplementary Figure S4). Collectively, these data indi-
cate that the CTIF-DDX19B interaction helps the nuclear
enrichment of CBP80, possibly by blocking the release of
CTIF into the cytoplasm.
DDX19B inhibits polysome association of the CT complex
What is the molecular function of the CTIF–DDX19B in-
teraction? Based on a previous study showing that CTIF as-
sociates with polysomes through its direct interaction with
CBP80 and thus preferentially directs efficient CT (6) and
the present study suggesting that disruption of the CTIF–
DDX19B interaction causes the accumulation of CBP80 in
the cytoplasm, we investigated the possible role of DDX19B
in CT. For this purpose, we assessed the relative distribu-
tions of CTIF-WT and CTIF-F460A in polysome gradi-
ents (Figure 5). Polysome fractionation experiments with
the cytoplasmic extracts of HEK293FT cells revealed that
a greater amount of CTIF-F460A than CTIF-WT was de-
tected in the polysomal fractions (Figure 5A and B). In ad-
dition, the expression of CTIF-F460A increased the asso-
ciation of CBP80 with polysomes (Figure 5A and C) with-
out significantly affecting the relative distribution of eIF4E
(Figure 5A and D). These data suggest that the interaction
between CTIF and DDX19B prevents the polysome asso-
ciation of the CT complex.
DDX19B inhibits the polysome association of CTIF in the
perinuclear region
Since the perinuclear localization of CTIF depends on
DDX19B (Figure 3), we reasoned that the increased asso-
ciation of CTIF-F460A with polysomes might be caused
either by its inability to interact with DDX19B or by the
relocalization of CTIF from the perinuclear region to the
cytoplasm. To clarify the underlying mechanism, we de-
signed FLAG-CTIF constructs (either WT or F460A) fused
to the Klarsicht, ANC-1, and syne homology 1 (KASH1)
domain of nesprin-1 (Figure 6A). The KASH1 domain has
been shown to target proteins on the cytoplasmic side of the
outer nuclear membrane (40). As expected, although CTIF-
WT and CTIF-F460A manifested perinuclear and cyto-
plasmic distributions, respectively, both CTIF-WT-KASH1
and CTIF-F460A-KASH1 predominantly localized to the
perinuclear region (Figure 6B). Overall, the fusion of CTIF-
WT or CTIF-F460A with KASH1 increased the association
between CTIF and CBP80 and between CTIF and eIF3b
compared with CTIF-WT or CTIF-F460A lacking KASH1
(Supplementary Figure S5), suggesting that artificial tether-
ing of CTIF to the perinuclear region increases the chance
that CTIF interacts with CBP80 and eIF3b. Remarkably,
CTIF-F460A-KASH1 was found to be more strongly en-
riched in the polysome fractions than CTIF-WT-KASH1
(Figure 6C and D). Taken together, these data indicate that
the association of the CT complex with polysomes is mostly
influenced by both the ability of CTIF to interact with
DDX19B and the perinuclear localization of CTIF.
Inhibition of the polysomal association of CTIF by DDX19B
occurs on CBC-bound mRNAs
Because CTIF is a specific factor responsible for efficient
CT (6), we next investigated whether DDX19B-mediated
inhibition of CTIF association with polysomes occurs dur-
ing CT. To this end, we conducted polysome fractiona-
tion experiments on cytoplasmic extracts of cells that sta-
bly expressed Myc-eIF4E and transiently expressed CBP80-
HA and either FLAG-CTIF-WT-KASH1 or FLAG-CTIF-
F460A-KASH1 (Figure 7). The polysome-fractionated
samples were then subjected to IPs with either -HA or -
Myc antibody to separate CBP80-bound messenger ribonu-
cleoproteins (mRNPs) and eIF4E-bound mRNPs. Specific
and efficient IPs of CBP80-HA or Myc-eIF4E and the rel-
ative distributions of coimmunoprecipitated FLAG-CTIF
were analyzed by western blotting (Figure 7A). In agree-
ment with our results from IPs (Figures 1 and 2), both
CTIF-WT-KASH1 and CTIF-F460A-KASH1 selectively
coimmunopurified with CBP80-HA but not with Myc-
eIF4E (Figure 7A), supporting that CTIF selectively asso-
ciates with the CBC-bound mRNP complex. Furthermore,
consistent with the polysome fractionation experiments in
Figure 6, CTIF-F460A-KASH1 was found to be more en-
riched in the polysome fractions before IP of CBP80-HA
in comparison to CTIF-WT-KASH1 (Figure 7A and B).
Notably, strong enrichment of CTIF-F460A-KASH1 in the
polysome fractions was still observed even after the IP of
CBP80-HA (Figure 7A and C). These data indicate that
DDX19B-mediated inhibition of CTIF association with
polysomes largely occurs on CBC-bound mRNPs rather
than on eIF4E-bound mRNPs.
Interaction between CTIF and DDX19B inhibits NMD
Given that (i) CTIF is a specific factor involved in CT (6),
(ii) CT plays an important role in NMD (1,2,11) and (iii)
DDX19B plays an inhibitory role in CT (Figures 5 and 6),
we hypothesized that an interaction between DDX19B and
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Figure 4. CTIF-DDX19B interaction helps the nuclear enrichment of CBP80. (A) Immunostaining of endogenous CBP80 and FLAG, FLAG-CTIF-WT
or FLAG-CTIF-F460A. HeLa cells transiently expressing FLAG, FLAG-CTIF-WT or FLAG-CTIF-F460A were stained with -CBP80 antibody (red),
-FLAG antibody (green), and DAPI (blue). The intensities of endogenous CBP80 (red) and FLAG-CTIF (green) along the white arrows are quantitated
and presented in the rightmost panel as a percentage of the sum of each intensity. Mean values and standard deviations of the relative intensities obtained
from 30 individual cells are shown as solid lines and semi-transparent lines, respectively. Scale bar, 10 m; n = 3; Scale bar, 10 m. (B) Immunostaining
of endogenous CBP80 in DDX19B-depleted cells. HeLa cells either depleted or not depleted of DDX19B were transiently transfected with a plasmid
expressing HA, DDX19BR-WT-HA or DDX19BR-W6A/V10A-HA. After fixation, the cells were stained with -CBP80 antibody (red) and DAPI (blue);
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Figure 5. CTIF unable to interact with DDX19B co-fractionates to a higher extent with polysomes. (A) Polysome fractionation analysis of FLAG-CTIF-
WT or of one of its variants. Cytoplasmic extracts of HEK293FT cells transiently expressing either FLAG-CTIF-WT or FLAG-CTIF-F460A were sub-
jected to polysome fractionation, followed by analysis of the protein samples in each fraction by western blotting with the indicated antibodies. The peaks
corresponding to the small ribosomal subunits, large ribosomal subunits, and monosomes are denoted as 40S, 60S, and 80S, respectively. (B) Quantitative
representation of the relative distribution of FLAG-CTIF-WT or FLAG-CTIF-F460A across the fractions. The intensities of FLAG-CTIF-WT or FLAG-
CTIF-F460A in each fraction of panel A were quantitated. To rule out any possibility or bias caused by differences in protein expression and exposure
time during western blotting, relative levels of FLAG-CTIF-WT (red) and FLAG-CTIF-F460A (blue) are presented as a percentage of the sum of the
intensities of the respective protein. Mean values and standard deviations from two biological replicates are shown. (C) Quantitative representation of the
relative levels of endogenous CBP80, as determined in panel B. (D) Quantitative representation of relative levels of endogenous eIF4E, as determined in
panel B.
pothesis, we compared the effects of overexpressed CTIF-
WT or CTIF-F460A on NMD efficiency of two NMD re-
porter mRNAs: globin mRNA (Figure 8A), which har-
bors either no PTC (Norm) or a PTC (Ter) at the 39th
codon of the globin gene (Gl) (41) and glutathione per-
oxidase 1 (GPx1) mRNA (Figure 8B), which harbors ei-
ther no PTC (Norm) or PTC (Ter) at the 46th codon
of GPx1 (42). Results of qRT-PCR revealed that overex-
pression of CTIF-F460A significantly reduced the abun-
dance of Gl-Ter mRNA (by ∼3.1-fold; Figure 8A) and
GPx1-Ter mRNA (by ∼2.7-fold; Figure 8B) as compared to
overexpression of CTIF-WT. Furthermore, overexpression
of CTIF-F460A increased the efficiency of NMD of pre-
viously known endogenous NMD substrates (COMMD7
mRNA and GADD45B mRNA) (Figure 8C and D). These
results indicate that the CTIF-DDX19B interaction plays
an inhibitory role in NMD.
DDX19B can act on multiple steps of translation, ei-
ther positively or negatively. For instance, DDX19B is
known to interact with eRF1, consequently promoting
translation termination (23–26). In contrast, we found that
DDX19B targets the initiation step of CT, inhibiting the
efficiency of CT. Because of the opposite functions of
DDX19B at different translation stages, it would be diffi-
cult to interpret the data obtained after DDX19B down-
regulation. To pinpoint the effect of the CTIF-DDX19B in-
teraction on NMD, we carried out complementation exper-
iments using DDX19B siRNA and DDX19BR either WT
or W6A/V10A variant (Figure 8E–I). Downregulation of
DDX19B inhibited NMD of reporter mRNAs by ∼2.3-
fold (Figure 8F and G) and endogenous NMD substrates
by ∼1.7–1.9-fold (Figure 8H and I), suggesting that the in-
hibitory effect of DDX19B on CT is masked by its promot-
ing effect on translation termination. Intriguingly, whereas
the expression of DDX19BR-WT almost completely res-
cued NMD efficiency, DDX19B-depleted cells express-
ing DDX19BR-W6A/V10A exhibited more efficient NMD
than those expressing DDX19BR-WT. Therefore, these
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Figure 6. DDX19B inhibits polysome association of CTIF in the perinuclear region. (A) Schematic illustration of FLAG-CTIF-WT-KASH1 and FLAG-
CTIF-F460A-KASH1. The FLAG tag, CBP80-interacting domain, MIF4G domain, and KASH1 domain are depicted. The position of the F460A muta-
tion is indicated by a black arrow. (B) Immunostaining of FLAG-CTIF-WT and its variants. HeLa cells transiently expressing the indicated protein were
subjected to immunostaining with -FLAG antibody (green) and DAPI (blue); n = 2; Scale bar, 10 m. (C) Polysome fractionation analysis of cytoplasmic
extracts of HEK293FT cells transiently expressing FLAG-CTIF-WT-KASH1 or FLAG-CTIF-F460A-KASH1. The protein samples in each fraction after
polysome fractionation experiments were analyzed by western blotting with -FLAG antibody. (D) Quantitative representation of relative distributions of
FLAG-CTIF-WT-KASH1 or FLAG-CTIF-F460A-KASH1. Mean values and standard deviations from three biological replicates are shown; n = 3; #,
not significant; *P < 0.05, **P < 0.01.
NMD inhibition by CTIF-DDX19B interaction mostly oc-
curs on CBC-bound mRNA
We next investigated whether the increase in NMD ef-
ficiency upon CTIF-F460A overexpression occurs on
mRNA bound by either CBC or eIF4E. To this end, we
carried out IPs in the extracts of cells expressing Gl re-
porter mRNA (either Norm or Ter) and CTIF (either WT
or F460A) with either an -CBP80 or -eIF4E antibody.
Endogenous CBP80, but not eIF4E, was specifically en-
riched in CBP80 IP, whereas endogenous eIF4E, but not
CBP80, was specifically enriched in eIF4E IP, confirming
the specificity of the IPs of endogenous CBP80 or eIF4E
(Figure 9A). The results of qRT-PCR of coimmunoprecip-
itated mRNAs showed significant reductions in the abun-
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Figure 7. Inhibition of polysome association of CTIF by DDX19B mainly occurs on CBC-bound mRNA. HEK293FT cells stably expressing Myc-eIF4E
were transiently co-transfected with a plasmid expressing CBP80-HA and a plasmid expressing either FLAG-CTIF-WT-KASH1 or FLAG-CTIF-F460A-
KASH1. The cytoplasmic extracts were subjected to polysome fractionation. Next, total fractions were pooled into seven fractions and subjected to IP
with either -HA antibody or -Myc antibody. (A) Relative distribution of the indicated proteins. Protein samples in each fraction before or after IP were
analyzed by western blotting. (B and C) Quantitative representation of the relative distribution of FLAG-CTIF-WT-KASH1 and FLAG-CTIF-F460A-
KASH1 across the gradient before (B) and after IP (C), as shown in Figure 5B–D; n = 3.
porter mRNAs upon overexpression of CTIF-F460A as
compared to those upon overexpression of CTIF-WT (Fig-
ure 9B). Considering that CBC-bound mRNAs are pre-
cursors of eIF4E-bound mRNAs (11,43), our observations
suggest that DDX19B largely inhibits the NMD of CBC-
bound mRNAs.
DISCUSSION
Translation within a specialized intracellular compartment
(e.g. the endoplasmic reticulum or axon of neurons) is sub-
ject to strict regulations. Otherwise, translation in inappro-
priate cellular compartments may cause cellular defects and
proteotoxic stress (44,45). In this regard, during or immedi-
ately after mRNA export, the regulation of appropriate as-
sembly of RNA-binding proteins into complexes with newly
exported mRNAs in the perinuclear region might be critical
for cell viability or functionality. In this study, we revealed
that CTIF interacts with DDX19B through the C-terminal
MIF4G domain of CTIF and the N-terminal extension re-
gion of DDX19B (Figures 1 and 2). The binding of CTIF
to DDX19B tethers CTIF to the perinuclear region (Figure
3) and hinders the interaction between CBP80 and CTIF
(Figure 2), thereby inhibiting the association of CTIF with
polysomes in the perinuclear region (Figure 5–7). Conse-
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Figure 8. Interaction between CTIF and DDX19B affects NMD. (A) The effect of overexpressed FLAG-CTIF-WT or FLAG-CTIF-F460A on NMD of
Gl reporter mRNAs. HEK293T cells were co-transfected with a plasmid expressing the Gl NMD reporter (either Norm or Ter), a phCMV-MUP reference
plasmid, and a plasmid expressing FLAG, FLAG-CTIF-WT, or FLAG-CTIF-F460A. The levels of Gl mRNA were normalized to those of MUP mRNA,
and the normalized levels of Gl Norm mRNA were arbitrarily set to 100%; n = 3; **P < 0.01. (B) The effect of overexpressed FLAG-CTIF-WT or
FLAG-CTIF-F460A on NMD of GPx1 reporter mRNAs. As performed in panel A, except that GPx1 NMD reporter mRNAs were analyzed; n = 3;
**P < 0.01. (C and D) The influence of overexpressed FLAG-CTIF-WT or FLAG-CTIF-F460A on endogenous NMD substrates, COMMD7 mRNA,
and GADD45B mRNA. The levels of COMMD7 mRNA (C) and GADD45B mRNA (D) were normalized to those of GAPDH mRNA; n = 3; **P <
0.01. (E–I) Complementation experiments using DDX19B siRNA and siRNA-resistant DDX19BR-HA. HEK293T cells either depleted or not depleted of
DDX19B were transiently co-transfected with a plasmid expressing NMD reporter (either Norm or Ter), phCMV-MUP reference plasmid, and plasmid
expressing HA, DDX19BR-WT-HA, or DDX19BR-W6A/V10A-HA. Specific downregulation of DDX19B and expression of DDX19BR-HA comparable
to that of endogenous DDX19B are shown in panel E. Normalized levels of Gl mRNA (F), GPx1 mRNA (G), endogenous COMMD7 mRNA (H) and
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Figure 9. Overexpression of CTIF-F460A increases NMD of mRNAs bound by CBP80. As performed in Figure 8A, except that the extracts of the cells
were subjected to IPs with either -CBP80 or -eIF4E antibody. Total cell protein and RNA were analyzed by western blotting (A) and qRT-PCR (B),
respectively; n = 3; *P < 0.05, **P < 0.01.
vented, and CT-coupled NMD is brought under tight con-
trol (Figures 8 and 9).
A previous study (6) and the present study showed that
CBP80 and DDX19B bind to the N- and C-terminal halves
of CTIF, respectively. Nonetheless, our results uncovered a
competition between CBP80 and DDX19B for binding to
CTIF (Figures 1 and 2). The observed competition may re-
sult from a possible conformational change in CTIF after
it interacts with either CBP80 or DDX19B. Alternatively,
the mutually exclusive interactions may be due to steric hin-
drance between CBP80 and DDX19B. Given that (i) CBP80
binds to a newly synthesized mRNA in the nucleus, (ii) the
mRNA is exported to the cytoplasm with CBP80 bound to
the 5′-cap structure and (iii) both CTIF and DDX19B are
mostly enriched in the perinuclear region, it is likely that
the CTIF-DDX19B interaction in the perinuclear region is
disrupted when CBP80-bound mRNA emerges on the cy-
toplasmic side of the nuclear envelope (Figure 10). The re-
sulting CBP80-CTIF-associated mRNA may then recruit
eIF3 and a small ribosomal subunit primed for translation
initiation (6,29,32), thereby initiating CT in the perinuclear
region. If the mRNA harbors a PTC, it may be rapidly de-
graded via NMD in the perinuclear region during CT. In the
support of this idea, temporal and spatial characterization
of NMD by single-RNA fluorescent in situ hybridization
revealed that a PTC-containing -globin reporter mRNA
is rapidly degraded immediately after its export to the cy-
toplasm (46). After CT, CTIF may translocate back to the
cytoplasmic side of the nuclear envelope through its interac-
tion with DDX19B. In this way, DDX19B may keep CTIF
tethered to the perinuclear region and allow for local CT of
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Figure 10. Working model of DDX19B-mediated CT regulation in the perinuclear region. See text in the Discussion for more details.
cytoplasmic CBP80 enters the nucleus and binds to newly
synthesized mRNAs for the next round of CT (Figure 4).
Although less effective than DDX19B, DDX19A also con-
tributes to the above-mentioned regulation in an additive
manner with DDX19B.
Failure of CTIF to interact with DDX19B causes the re-
lease of CTIF from the perinuclear region and its distribu-
tion across the entire cytoplasm (Figure 3). The released
CTIF may be more accessible to CBP80, thus leading to un-
controlled CT in inappropriate cellular compartments. Ac-
cordingly, NMD would then be less restricted to the per-
inuclear region and could instead proceed throughout the
cytoplasm, resulting in an overall higher efficiency (Figures
8 and 9). Active NMD in inappropriate cellular compart-
ments may be deleterious to the cell because it is believed
that NMD acts as a double-edged sword, and its efficiency
should be properly regulated depending on the cellular en-
vironment (14,47). For instance, proper regulation of NMD
efficiency is crucial for animal development, self-renewal
of embryonic or neural stem cells, and differentiation of
stem cells (48–52). Therefore, inappropriate NMD regula-
tion caused by the lack of a controlled hand-over of CTIF
from DDX19B to CBP80 may be detrimental to normal
cell functions. Alternatively, the NMD substrates that es-
cape tight regulation through the CTIF-DDX19B interac-
tion may be subject to another surveillance pathway, that is,
NMD occurring on eIF4E-associated mRNAs (53,54). Fu-
ture studies will address the molecular details of local trans-
lation in the perinuclear region.
DATA AVAILABILITY
The data that support the findings of this study are available
from the corresponding author upon reasonable request.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
FUNDING
National Research Foundation (NRF) of Korea grant
funded by the Korean government (Ministry of Science,
ICT and Future Planning) [NRF-2015R1A3A2033665,
NRF-2018R1A5A1024261]; Korea University Grant.
Funding for open access charge: National Research
Foundation (NRF) of Korea [NRF-2015R1A3A2033665].
Conflict of interest statement. None declared.
REFERENCES
1. Maquat,L.E., Tarn,W.Y. and Isken,O. (2010) The pioneer round of
translation: features and functions. Cell, 142, 368–374.
2. Ryu,I. and Kim,Y.K. (2017) Translation initiation mediated by
nuclear cap-binding protein complex. BMB Reports, 50, 186–193.
3. Gonatopoulos-Pournatzis,T. and Cowling,V.H. (2014) Cap-binding
complex (CBC). Biochem. J., 457, 231–242.
4. Muller-McNicoll,M. and Neugebauer,K.M. (2014) Good cap/bad
cap: how the cap-binding complex determines RNA fate. Nat. Struct.
Mol. Biol., 21, 9–12.
5. Katahira,J. (2015) Nuclear export of messenger RNA. Genes, 6,
163–184.
6. Kim,K.M., Cho,H., Choi,K., Kim,J., Kim,B.W., Ko,Y.G., Jang,S.K.
and Kim,Y.K. (2009) A new MIF4G domain-containing protein,
CTIF, directs nuclear cap-binding protein CBP80/20-dependent
translation. Genes Dev., 23, 2033–2045.
7. Sato,H. and Maquat,L.E. (2009) Remodeling of the pioneer
translation initiation complex involves translation and the
karyopherin importin beta. Genes Dev., 23, 2537–2550.
8. Dias,S.M., Wilson,K.F., Rojas,K.S., Ambrosio,A.L. and
Cerione,R.A. (2009) The molecular basis for the regulation of the
cap-binding complex by the importins. Nat. Struct. Mol. Biol., 16,
930–937.
9. Jeong,K., Ryu,I., Park,J., Hwang,H.J., Ha,H., Park,Y., Oh,S.T. and
Kim,Y.K. (2019) Staufen1 and UPF1 exert opposite actions on the
replacement of the nuclear cap-binding complex by eIF4E at the 5′
end of mRNAs. Nucleic Acids Res., 47, 9313–9328.
10. Tahmasebi,S., Khoutorsky,A., Mathews,M.B. and Sonenberg,N.
(2018) Translation deregulation in human disease. Nat. Rev. Mol. Cell
Biol., 19, 791–807.
11. Ishigaki,Y., Li,X., Serin,G. and Maquat,L.E. (2001) Evidence for a
pioneer round of mRNA translation: mRNAs subject to
nonsense-mediated decay in mammalian cells are bound by CBP80
and CBP20. Cell, 106, 607–617.
12. Maquat,L.E., Hwang,J., Sato,H. and Tang,Y. (2010)
CBP80-promoted mRNP rearrangements during the pioneer round
of translation, nonsense-mediated mRNA decay, and thereafter. Cold
Spring Harb. Symp. Quant. Biol., 75, 127–134.
13. Kim,Y.K. and Maquat,L.E. (2019) UPFront and center in RNA
decay: UPF1 in nonsense-mediated mRNA decay and beyond. RNA,
25, 407–422.
14. Kurosaki,T., Popp,M.W. and Maquat,L.E. (2019) Quality and
quantity control of gene expression by nonsense-mediated mRNA







niversitaetsbibliothek Bern user on 09 July 2021
16 Nucleic Acids Research, 2021
15. Park,J., Park,Y., Ryu,I., Choi,M.H., Lee,H.J., Oh,N., Kim,K.,
Kim,K.M., Choe,J., Lee,C. et al. (2017) Misfolded polypeptides are
selectively recognized and transported toward aggresomes by a CED
complex. Nat. Commun., 8, 15730.
16. Park,Y., Park,J. and Kim,Y.K. (2017) Crosstalk between translation
and the aggresome-autophagy pathway. Autophagy, 14, 1079–1081.
17. Park,Y., Park,J., Hwang,H.J., Kim,B., Jeong,K., Chang,J., Lee,J.B.
and Kim,Y.K. (2020) Nonsense-mediated mRNA decay factor UPF1
promotes aggresome formation. Nat. Commun., 11, 3106.
18. Collins,R., Karlberg,T., Lehtio,L., Schutz,P., van den Berg,S.,
Dahlgren,L.G., Hammarstrom,M., Weigelt,J. and Schuler,H. (2009)
The DEXD/H-box RNA helicase DDX19 is regulated by an
{alpha}-helical switch. J. Biol. Chem., 284, 10296–10300.
19. Tieg,B. and Krebber,H. (2013) Dbp5 - from nuclear export to
translation. Biochim. Biophys. Acta, 1829, 791–798.
20. Napetschnig,J., Kassube,S.A., Debler,E.W., Wong,R.W., Blobel,G.
and Hoelz,A. (2009) Structural and functional analysis of the
interaction between the nucleoporin Nup214 and the DEAD-box
helicase Ddx19. PNAS, 106, 3089–3094.
21. Montpetit,B., Thomsen,N.D., Helmke,K.J., Seeliger,M.A.,
Berger,J.M. and Weis,K. (2011) A conserved mechanism of
DEAD-box ATPase activation by nucleoporins and InsP6 in mRNA
export. Nature, 472, 238–242.
22. Lin,D.H., Correia,A.R., Cai,S.W., Huber,F.M., Jette,C.A. and
Hoelz,A. (2018) Structural and functional analysis of mRNA export
regulation by the nuclear pore complex. Nat. Commun., 9, 2319.
23. Gross,T., Siepmann,A., Sturm,D., Windgassen,M., Scarcelli,J.J.,
Seedorf,M., Cole,C.N. and Krebber,H. (2007) The DEAD-box RNA
helicase Dbp5 functions in translation termination. Science (New
York, N.Y.), 315, 646–649.
24. Beissel,C., Neumann,B., Uhse,S., Hampe,I., Karki,P. and Krebber,H.
(2019) Translation termination depends on the sequential ribosomal
entry of eRF1 and eRF3. Nucleic Acids Res., 47, 4798–4813.
25. Beissel,C., Grosse,S. and Krebber,H. (2020) Dbp5/DDX19 between
translational readthrough and nonsense mediated decay. Int. J. Mol.
Sci., 21, 1085.
26. Mikhailova,T., Shuvalova,E., Ivanov,A., Susorov,D., Shuvalov,A.,
Kolosov,P.M. and Alkalaeva,E. (2017) RNA helicase DDX19
stabilizes ribosomal elongation and termination complexes. Nucleic
Acids Res., 45, 1307–1318.
27. Oh,N., Kim,K.M., Cho,H., Choe,J. and Kim,Y.K. (2007) Pioneer
round of translation occurs during serum starvation. Biochem.
Biophys. Res. Commun., 362, 145–151.
28. Cho,H., Han,S., Park,O.H. and Kim,Y.K. (2013) SMG1 regulates
adipogenesis via targeting of staufen1-mediated mRNA decay.
Biochim. Biophys. Acta, 1829, 1276–1287.
29. Choe,J., Oh,N., Park,S., Lee,Y.K., Song,O.K., Locker,N., Chi,S.G.
and Kim,Y.K. (2012) Translation initiation on mRNAs bound by
nuclear cap-binding protein complex CBP80/20 requires interaction
between CBP80/20-dependent translation initiation factor and
eukaryotic translation initiation factor 3g. J. Biol. Chem., 287,
18500–18509.
30. Shyu,Y.J., Liu,H., Deng,X. and Hu,C.D. (2006) Identification of new
fluorescent protein fragments for bimolecular fluorescence
complementation analysis under physiological conditions.
BioTechniques, 40, 61–66.
31. Cho,H., Park,O.H., Park,J., Ryu,I., Kim,J., Ko,J. and Kim,Y.K.
(2015) Glucocorticoid receptor interacts with PNRC2 in a
ligand-dependent manner to recruit UPF1 for rapid mRNA
degradation. PNAS, 112, E1540–E1549.
32. Choe,J., Ryu,I., Park,O.H., Park,J., Cho,H., Yoo,J.S., Chi,S.W.,
Kim,M.K., Song,H.K. and Kim,Y.K. (2014) eIF4AIII enhances
translation of nuclear cap-binding complex-bound mRNAs by
promoting disruption of secondary structures in 5′UTR. PNAS, 111,
E4577–E4586.
33. Park,O.H., Park,J., Yu,M., An,H.T., Ko,J. and Kim,Y.K. (2016)
Identification and molecular characterization of cellular factors
required for glucocorticoid receptor-mediated mRNA decay. Genes
Dev., 30, 2093–2105.
34. Ryu,I., Won,Y.S., Ha,H., Kim,E., Park,Y., Kim,M.K., Kwon,D.H.,
Choe,J., Song,H.K., Jung,H. et al. (2019) eIF4A3 phosphorylation by
CDKs Affects NMD during the Cell Cycle. Cell Rep., 26, 2126–2139.
35. Kerppola,T.K. (2006) Design and implementation of bimolecular
fluorescence complementation (BiFC) assays for the visualization of
protein interactions in living cells. Nat. Protoc., 1, 1278–1286.
36. Choe,J., Kim,K.M., Park,S., Lee,Y.K., Song,O.K., Kim,M.K.,
Lee,B.G., Song,H.K. and Kim,Y.K. (2013) Rapid degradation of
replication-dependent histone mRNAs largely occurs on mRNAs
bound by nuclear cap-binding proteins 80 and 20. Nucleic Acids Res.,
41, 1307–1318.
37. von Moeller,H., Lerner,R., Ricciardi,A., Basquin,C., Marzluff,W.F.
and Conti,E. (2013) Structural and biochemical studies of
SLIP1-SLBP identify DBP5 and eIF3g as SLIP1-binding proteins.
Nucleic Acids Res., 41, 7960–7971.
38. Schmitt,C., von Kobbe,C., Bachi,A., Pante,N., Rodrigues,J.P.,
Boscheron,C., Rigaut,G., Wilm,M., Seraphin,B., Carmo-Fonseca,M.
et al. (1999) Dbp5, a DEAD-box protein required for mRNA export,
is recruited to the cytoplasmic fibrils of nuclear pore complex via a
conserved interaction with CAN/Nup159p. EMBO J., 18, 4332–4347.
39. von Moeller,H., Basquin,C. and Conti,E. (2009) The mRNA export
protein DBP5 binds RNA and the cytoplasmic nucleoporin NUP214
in a mutually exclusive manner. Nat. Struct. Mol. Biol., 16, 247–254.
40. Wilhelmsen,K., Ketema,M., Truong,H. and Sonnenberg,A. (2006)
KASH-domain proteins in nuclear migration, anchorage and other
processes. J. Cell Sci., 119, 5021–5029.
41. Zhang,J., Sun,X., Qian,Y. and Maquat,L.E. (1998) Intron function in
the nonsense-mediated decay of beta-globin mRNA: indications that
pre-mRNA splicing in the nucleus can influence mRNA translation in
the cytoplasm. RNA, 4, 801–815.
42. Moriarty,P.M., Reddy,C.C. and Maquat,L.E. (1998) Selenium
deficiency reduces the abundance of mRNA for Se-dependent
glutathione peroxidase 1 by a UGA-dependent mechanism likely to
be nonsense codon-mediated decay of cytoplasmic mRNA. Mol. Cell.
Biol., 18, 2932–2939.
43. Lejeune,F., Ishigaki,Y., Li,X. and Maquat,L.E. (2002) The exon
junction complex is detected on CBP80-bound but not eIF4E-bound
mRNA in mammalian cells: dynamics of mRNP remodeling. EMBO
J., 21, 3536–3545.
44. Costa,C.J. and Willis,D.E. (2018) To the end of the line: Axonal
mRNA transport and local translation in health and
neurodegenerative disease. Dev. Neurobiol., 78, 209–220.
45. Costa,E.A., Subramanian,K., Nunnari,J. and Weissman,J.S. (2018)
Defining the physiological role of SRP in protein-targeting efficiency
and specificity. Science (New York, N.Y.), 359, 689–692.
46. Trcek,T., Sato,H., Singer,R.H. and Maquat,L.E. (2013) Temporal
and spatial characterization of nonsense-mediated mRNA decay.
Genes Dev., 27, 541–551.
47. Han,X., Wei,Y., Wang,H., Wang,F., Ju,Z. and Li,T. (2018)
Nonsense-mediated mRNA decay: a ‘nonsense’ pathway makes sense
in stem cell biology. Nucleic Acids Res., 46, 1038–1051.
48. Jaffrey,S.R. and Wilkinson,M.F. (2018) Nonsense-mediated RNA
decay in the brain: emerging modulator of neural development and
disease. Nat. Rev. Neurosci., 19, 715–728.
49. Li,T., Shi,Y., Wang,P., Guachalla,L.M., Sun,B., Joerss,T., Chen,Y.S.,
Groth,M., Krueger,A., Platzer,M. et al. (2015) Smg6/Est1 licenses
embryonic stem cell differentiation via nonsense-mediated mRNA
decay. EMBO J., 34, 1630–1647.
50. Lou,C.H., Dumdie,J., Goetz,A., Shum,E.Y., Brafman,D., Liao,X.,
Mora-Castilla,S., Ramaiah,M., Cook-Andersen,H., Laurent,L. et al.
(2016) Nonsense-mediated RNA decay influences human embryonic
stem cell fate. Stem Cell Reports, 6, 844–857.
51. Wong,J.J., Ritchie,W., Ebner,O.A., Selbach,M., Wong,J.W.,
Huang,Y., Gao,D., Pinello,N., Gonzalez,M., Baidya,K. et al. (2013)
Orchestrated intron retention regulates normal granulocyte
differentiation. Cell, 154, 583–595.
52. Nasif,S., Contu,L. and Muhlemann,O. (2018) Beyond quality
control: the role of nonsense-mediated mRNA decay (NMD) in
regulating gene expression. Semin. Cell Dev. Biol., 75, 78–87.
53. Durand,S. and Lykke-Andersen,J. (2013) Nonsense-mediated mRNA
decay occurs during eIF4F-dependent translation in human cells.
Nat. Struct. Mol. Biol., 20, 702–709.
54. Rufener,S.C. and Muhlemann,O. (2013) eIF4E-bound mRNPs are
substrates for nonsense-mediated mRNA decay in mammalian cells.







niversitaetsbibliothek Bern user on 09 July 2021
